Aviva PLC Sells 8,300 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Aviva PLC lowered its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating) by 41.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,712 shares of the company’s stock after selling 8,300 shares during the quarter. Aviva PLC owned about 0.09% of U.S. Physical Therapy worth $949,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Point72 Hong Kong Ltd acquired a new position in U.S. Physical Therapy during the third quarter valued at approximately $45,000. Lazard Asset Management LLC lifted its position in U.S. Physical Therapy by 754.7% during the 1st quarter. Lazard Asset Management LLC now owns 453 shares of the company’s stock worth $45,000 after acquiring an additional 400 shares during the last quarter. Fifth Third Bancorp boosted its holdings in U.S. Physical Therapy by 13.4% during the fourth quarter. Fifth Third Bancorp now owns 916 shares of the company’s stock valued at $74,000 after acquiring an additional 108 shares during the period. Quantbot Technologies LP acquired a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $76,000. Finally, Center for Financial Planning Inc. increased its stake in shares of U.S. Physical Therapy by 3,351.7% in the fourth quarter. Center for Financial Planning Inc. now owns 1,001 shares of the company’s stock worth $81,000 after purchasing an additional 972 shares during the period. Institutional investors and hedge funds own 98.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. StockNews.com started coverage on U.S. Physical Therapy in a report on Thursday. They issued a “hold” rating on the stock. TheStreet upgraded shares of U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research note on Friday, May 5th. Finally, Barrington Research upped their target price on shares of U.S. Physical Therapy from $110.00 to $116.00 in a research note on Friday, May 5th.

U.S. Physical Therapy Trading Up 1.4 %

Shares of USPH opened at $113.87 on Monday. The stock’s 50-day moving average price is $102.86 and its 200 day moving average price is $94.87. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 52.72, a P/E/G ratio of 4.34 and a beta of 1.35. U.S. Physical Therapy, Inc. has a 12-month low of $73.30 and a 12-month high of $131.50.

U.S. Physical Therapy (NYSE:USPHGet Rating) last issued its earnings results on Wednesday, May 3rd. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. U.S. Physical Therapy had a return on equity of 10.93% and a net margin of 5.40%. The business had revenue of $148.51 million during the quarter, compared to analyst estimates of $140.77 million. During the same period in the prior year, the company posted $0.65 earnings per share. U.S. Physical Therapy’s revenue was up 12.8% on a year-over-year basis. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.63 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 9th. Stockholders of record on Thursday, May 18th will be given a dividend of $0.43 per share. The ex-dividend date of this dividend is Wednesday, May 17th. This represents a $1.72 annualized dividend and a dividend yield of 1.51%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 79.63%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 471 shares of the firm’s stock in a transaction dated Monday, March 13th. The shares were sold at an average price of $95.80, for a total transaction of $45,121.80. Following the completion of the transaction, the chief financial officer now owns 14,886 shares in the company, valued at $1,426,078.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Carey P. Hendrickson sold 471 shares of the business’s stock in a transaction on Monday, March 13th. The shares were sold at an average price of $95.80, for a total value of $45,121.80. Following the sale, the chief financial officer now owns 14,886 shares in the company, valued at approximately $1,426,078.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Eric Joseph Williams sold 1,150 shares of the stock in a transaction dated Friday, March 3rd. The stock was sold at an average price of $101.66, for a total transaction of $116,909.00. Following the sale, the insider now owns 12,714 shares of the company’s stock, valued at approximately $1,292,505.24. The disclosure for this sale can be found here. Insiders have sold a total of 4,814 shares of company stock valued at $484,853 over the last quarter. 1.80% of the stock is owned by company insiders.

U.S. Physical Therapy Profile

(Get Rating)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services.

Featured Articles

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.